ArticleJournal of clinical and translational hepatology2021

SGLT2 Inhibitors: A New Dawn for Recurrent/Refractory Cirrhotic Ascites.

Yuan Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.